These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32190695)

  • 41. Uric Acid is independently associated with diabetic kidney disease: a cross-sectional study in a Chinese population.
    Yan D; Tu Y; Jiang F; Wang J; Zhang R; Sun X; Wang T; Wang S; Bao Y; Hu C; Jia W
    PLoS One; 2015; 10(6):e0129797. PubMed ID: 26029914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. LC-MS-based metabolomics analysis to identify meprin-β-associated changes in kidney tissue from mice with STZ-induced type 1 diabetes and diabetic kidney injury.
    Gooding J; Cao L; Ahmed F; Mwiza JM; Fernander M; Whitaker C; Acuff Z; McRitchie S; Sumner S; Ongeri EM
    Am J Physiol Renal Physiol; 2019 Oct; 317(4):F1034-F1046. PubMed ID: 31411076
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Metabolite Profiling of the Gut-Renal-Cerebral Axis Reveals a Particular Pattern in Early Diabetic Kidney Disease in T2DM Patients.
    Balint L; Socaciu C; Socaciu AI; Vlad A; Gadalean F; Bob F; Milas O; Cretu OM; Suteanu-Simulescu A; Glavan M; Ienciu S; Mogos M; Jianu DC; Petrica L
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047187
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolomic Markers of Kidney Function Decline in Patients With Diabetes: Evidence From the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Kwan B; Fuhrer T; Zhang J; Darshi M; Van Espen B; Montemayor D; de Boer IH; Dobre M; Hsu CY; Kelly TN; Raj DS; Rao PS; Saraf SL; Scialla J; Waikar SS; Sharma K; Natarajan L;
    Am J Kidney Dis; 2020 Oct; 76(4):511-520. PubMed ID: 32387023
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Urinary metabolites associate with the presence of diabetic kidney disease in type 2 diabetes and mediate the effect of inflammation on kidney complication.
    Shi C; Wan Y; He A; Wu X; Shen X; Zhu X; Yang J; Zhou Y
    Acta Diabetol; 2023 Sep; 60(9):1199-1207. PubMed ID: 37184672
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Metabolic changes in urine and serum during progression of diabetic kidney disease in a mouse model.
    Kim NH; Hyeon JS; Kim NH; Cho A; Lee G; Jang SY; Kim MK; Lee EY; Chung CH; Ha H; Hwang GS
    Arch Biochem Biophys; 2018 May; 646():90-97. PubMed ID: 29621522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Real-World Diagnosis and Treatment of Diabetic Kidney Disease.
    Rodriguez F; Lee DJ; Gad SS; Santos MP; Beetel RJ; Vasey J; Bailey RA; Patel A; Blais J; Weir MR; Dash R
    Adv Ther; 2021 Aug; 38(8):4425-4441. PubMed ID: 34254257
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diabetic kidney disease in patients with type 2 diabetes mellitus: a cross-sectional study.
    Farah RI; Al-Sabbagh MQ; Momani MS; Albtoosh A; Arabiat M; Abdulraheem AM; Aljabiri H; Abufaraj M
    BMC Nephrol; 2021 Jun; 22(1):223. PubMed ID: 34134654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Research status and prospect of novel biomarkers for diabetic kidney disease].
    Feng ST; Wang B; Liu BC
    Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(10):691-694. PubMed ID: 33721945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Metabolomic Profiling of Amino Acids in Human Plasma Distinguishes Diabetic Kidney Disease From Type 2 Diabetes Mellitus.
    Zhou C; Zhang Q; Lu L; Wang J; Liu D; Liu Z
    Front Med (Lausanne); 2021; 8():765873. PubMed ID: 34912824
    [No Abstract]   [Full Text] [Related]  

  • 51. Association between Thyroid Hormone Levels and Diabetic Kidney Disease in Euthyroid Patients with Type 2 Diabetes.
    Zou J; Tian F; Zhang Y; Li Z; Yang C; Chen H; Zhai J; Shi M; Xu C; Zhang J; Li W; Xie Y; Li X
    Sci Rep; 2018 Mar; 8(1):4728. PubMed ID: 29549262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Retrospective Analysis of Hematologic Parameters in Patients with Early Diabetic Kidney Disease.
    Chen X; Wang Q; Li C
    Clin Appl Thromb Hemost; 2022; 28():10760296221083681. PubMed ID: 35249376
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Lipoprotein-associated phospholipase A2 is a risk factor for diabetic kidney disease.
    Hu Y; Li TT; Zhou W; Lu TT; Li FF; Ding B; Liu BL; Xie XJ; Ma JH
    Diabetes Res Clin Pract; 2019 Apr; 150():194-201. PubMed ID: 30904742
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Elevated serum level of pancreatic stone protein/regenerating protein (PSP/reg) is observed in diabetic kidney disease.
    Li L; Jia D; Graf R; Yang J
    Oncotarget; 2017 Jun; 8(24):38145-38151. PubMed ID: 28418911
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Changes in urinary exosomal protein CALM1 may serve as an early noninvasive biomarker for diagnosing diabetic kidney disease.
    Li T; Ci Liu T; Liu N; Zhang M
    Clin Chim Acta; 2023 Jul; 547():117466. PubMed ID: 37406751
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The association of erythrocyte sedimentation rate, high-sensitivity C-reactive protein and diabetic kidney disease in patients with type 2 diabetes.
    Guo S; Wang M; Yu Y; Yang Y; Zeng F; Sun F; Li Q; He M; Li Y; Wen J; Gong W; Zhang Z
    BMC Endocr Disord; 2020 Jul; 20(1):103. PubMed ID: 32660469
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-Throughput Metabolomics and Diabetic Kidney Disease Progression: Evidence from the Chronic Renal Insufficiency (CRIC) Study.
    Zhang J; Fuhrer T; Ye H; Kwan B; Montemayor D; Tumova J; Darshi M; Afshinnia F; Scialla JJ; Anderson A; Porter AC; Taliercio JJ; Rincon-Choles H; Rao P; Xie D; Feldman H; Sauer U; Sharma K; Natarajan L
    Am J Nephrol; 2022; 53(2-3):215-225. PubMed ID: 35196658
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol.
    Gooding KM; Lienczewski C; Papale M; Koivuviita N; Maziarz M; Dutius Andersson AM; Sharma K; Pontrelli P; Garcia Hernandez A; Bailey J; Tobin K; Saunavaara V; Zetterqvist A; Shelley D; Teh I; Ball C; Puppala S; Ibberson M; Karihaloo A; Metsärinne K; Banks RE; Gilmour PS; Mansfield M; Gilchrist M; de Zeeuw D; Heerspink HJL; Nuutila P; Kretzler M; Welberry Smith M; Gesualdo L; Andress D; Grenier N; Shore AC; Gomez MF; Sourbron S;
    BMC Nephrol; 2020 Jun; 21(1):242. PubMed ID: 32600374
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Quantitative profiling of carboxylic compounds by gas chromatography-mass spectrometry for revealing biomarkers of diabetic kidney disease.
    Zhu R; Yuan Y; Qi R; Liang J; Shi Y; Weng H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 Dec; 1231():123930. PubMed ID: 38029665
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical predictive factors in diabetic kidney disease progression.
    Radcliffe NJ; Seah JM; Clarke M; MacIsaac RJ; Jerums G; Ekinci EI
    J Diabetes Investig; 2017 Jan; 8(1):6-18. PubMed ID: 27181363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.